
No 24-hour summary has been generated yet.
Latest saved period: December 2025 · 2025-12-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| May 12, 2023 | $1.63 | Jun 1, 2023 | Other |
| Mar 19, 2020 | $0.14 | Mar 30, 2020 | Quarterly |
| Dec 19, 2019 | $0.14 | Dec 30, 2019 | Quarterly |
| Sep 19, 2019 | $0.14 | Sep 30, 2019 | Quarterly |
| Jun 20, 2019 | $0.14 | Jun 28, 2019 | Quarterly |
| Mar 20, 2019 | $0.14 | Mar 29, 2019 | Quarterly |
| Dec 20, 2018 | $0.14 | Dec 28, 2018 | Quarterly |
| Sep 20, 2018 | $0.14 | Sep 28, 2018 | Quarterly |
| Jun 20, 2018 | $0.14 | Jun 29, 2018 | Quarterly |
| Mar 20, 2018 | $0.14 | Mar 30, 2018 | Quarterly |
| Dec 20, 2017 | $0.14 | Dec 29, 2017 | Quarterly |
| Sep 20, 2017 | $0.14 | Sep 29, 2017 | Quarterly |
| Jun 19, 2017 | $0.14 | Jun 30, 2017 | Quarterly |
| Mar 17, 2017 | $0.14 | Mar 30, 2017 | Quarterly |
| Dec 19, 2016 | $0.13 | Dec 30, 2016 | Quarterly |
| Sep 19, 2016 | $0.13 | Sep 30, 2016 | Quarterly |
| Jun 17, 2016 | $0.13 | Jun 30, 2016 | Quarterly |
| Mar 17, 2016 | $0.13 | Mar 30, 2016 | Quarterly |
| Dec 17, 2015 | $0.09 | Dec 30, 2015 | Quarterly |
| Sep 17, 2015 | $0.09 | Sep 30, 2015 | Quarterly |
| Jun 17, 2015 | $0.09 | Jun 30, 2015 | Quarterly |
| Mar 12, 2015 | $0.09 | Mar 30, 2015 | Quarterly |
| Dec 11, 2014 | $0.09 | Dec 30, 2014 | Quarterly |
| Aug 27, 2014 | $0.09 | Sep 16, 2014 | Other |
Wrqti brings Sabre Corpo data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the same sector you can compare with Sabre Corpo:
Compare Sabre Corpo head-to-head with:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: December 2025.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.